Targeting inflammation in diabetic kidney disease: early clinical trials
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting inflammation in diabetic kidney disease: early clinical trials
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 25, Issue 9, Pages 1045-1058
Publisher
Informa UK Limited
Online
2016-06-07
DOI
10.1080/13543784.2016.1196184
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NADPH oxidase 5 and renal disease
- (2015) Chet E. Holterman et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy
- (2015) Jay C. Jha et al. DIABETOLOGIA
- Translational value of animal models of kidney failure
- (2015) Alberto Ortiz et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Lyso-Gb3 activates Notch1 in human podocytes
- (2015) Maria D. Sanchez-Niño et al. HUMAN MOLECULAR GENETICS
- Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance
- (2015) I M Khan et al. INTERNATIONAL JOURNAL OF OBESITY
- Phosphodiesterase type 5 inhibitors and kidney disease
- (2015) Baris Afsar et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
- (2015) Theo Vos et al. LANCET
- Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition
- (2015) Christopher J L Murray et al. LANCET
- Innate immunity in diabetes and diabetic nephropathy
- (2015) Jun Wada et al. Nature Reviews Nephrology
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Excess Mortality among Persons with Type 2 Diabetes
- (2015) Mauro Tancredi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Albumin-induced apoptosis of tubular cells is modulated by BASP1
- (2015) M D Sanchez-Niño et al. Cell Death & Disease
- Crystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2
- (2015) Dominik Oberthür et al. Nature Communications
- Paricalcitol Inhibits Aldosterone-Induced Proinflammatory Factors by Modulating Epidermal Growth Factor Receptor Pathway in Cultured Tubular Epithelial Cells
- (2015) Jose L. Morgado-Pascual et al. Biomed Research International
- Humble kidneys predict mighty heart troubles
- (2015) Alberto Ortiz et al. Lancet Diabetes & Endocrinology
- The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial
- (2015) Dick de Zeeuw et al. Lancet Diabetes & Endocrinology
- The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries
- (2015) Laurent Calvier et al. JACC-Heart Failure
- Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade
- (2015) Maria Perez-Gomez et al. Journal of Clinical Medicine
- Novel Therapies for Diabetic Kidney Disease
- (2014) Radica Z. Alicic et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Calorie restriction mimicking effects of roflumilast prevents diabetic nephropathy
- (2014) Kulbhushan Tikoo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ask1Gene Deletion Blocks Maternal Diabetes–Induced Endoplasmic Reticulum Stress in the Developing Embryo by Disrupting the Unfolded Protein Response Signalosome
- (2014) Fang Wang et al. DIABETES
- Phosphodiesterase Inhibitors for Chronic Obstructive Pulmonary Disease: What Does the Future Hold?
- (2014) Maria Gabriella Matera et al. DRUGS
- Blocking Ligand Occupancy of the αVβ3 Integrin Inhibits the Development of Nephropathy in Diabetic Pigs
- (2014) Laura A. Maile et al. ENDOCRINOLOGY
- Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease
- (2014) Nathalie Esser et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Apoptosis signal-regulating kinase 1 as a therapeutic target
- (2014) Yosuke Kawarazaki et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Role of chemokines in proteinuric kidney disorders
- (2014) Juan Antonio Moreno et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Quantitative analyses of CTP-499 and five major metabolites by core-structure analysis
- (2014) Xiaonan Tang et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Molecular mechanisms of diabetic kidney disease
- (2014) Kimberly Reidy et al. JOURNAL OF CLINICAL INVESTIGATION
- Cutting It Out: ENaC Processing in the Human Nephron
- (2014) E. C. Ray et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of Pentoxifylline on Renal Function and Urinary Albumin Excretion in Patients with Diabetic Kidney Disease: The PREDIAN Trial
- (2014) J. F. Navarro-Gonzalez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Targeting inflammation in the treatment of type 2 diabetes: time to start
- (2014) Marc Y. Donath NATURE REVIEWS DRUG DISCOVERY
- Therapeutic approaches to diabetic nephropathy—beyond the RAS
- (2014) Beatriz Fernandez-Fernandez et al. Nature Reviews Nephrology
- TWEAK and the progression of renal disease: clinical translation
- (2014) A. B. Sanz et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Horses for Courses: Promoting Transparent Reporting of Qualitative Research in AJKD
- (2013) Allison Tong et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Involvement of ASK1–p38 pathway in the pathogenesis of diabetes triggered by pancreatic ß cell exhaustion
- (2013) Kiyoshi Yamaguchi et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function
- (2013) E. I. Ekinci et al. DIABETES CARE
- Standards of Medical Care in Diabetes--2014
- (2013) DIABETES CARE
- Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: A prospective study
- (2013) Jacobien C. Verhave et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- TWEAK transactivation of the epidermal growth factor receptor mediates renal inflammation
- (2013) Sandra Rayego-Mateos et al. JOURNAL OF PATHOLOGY
- Klotho to Treat Kidney Fibrosis
- (2013) M. D. Sanchez-Nino et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Kidney Infection with HIV-1 Following Kidney Transplantation
- (2013) P. G. Stock JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- (2013) Antoinette Moran et al. LANCET
- Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes
- (2013) Timothy J. Sullivan et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice
- (2013) S. J. Seok et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- HCV Infection and Miravirsen
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy?
- (2013) Usha Panchapakesan et al. PLoS One
- TWEAK/Fn14 and Non-Canonical NF-kappaB Signaling in Kidney Disease
- (2013) Jonay Poveda et al. Frontiers in Immunology
- Bindarit
- (2012) Eugenio Mora et al. CELL CYCLE
- AG490 Promotes HIF-1α Accumulation by Inhibiting Its Hydroxylation
- (2012) R. Fernandez-Sanchez et al. CURRENT MEDICINAL CHEMISTRY
- Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
- (2012) C. Cavelti-Weder et al. DIABETES CARE
- The glucose-lowering effects of the PDE4 inhibitors roflumilast and roflumilast-N-oxide in db/db mice
- (2012) S. Vollert et al. DIABETOLOGIA
- Targeting chemokines in proteinuria-induced renal disease
- (2012) Juan Antonio Moreno et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Effect of the Phosphodiesterase 4 Inhibitor Roflumilast on Glucose Metabolism in Patients with Treatment-Naive, Newly Diagnosed Type 2 Diabetes Mellitus
- (2012) E. F. M. Wouters et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- One Target—Two Different Binding Modes: Structural Insights into Gevokizumab and Canakinumab Interactions to Interleukin-1β
- (2012) Michaela Blech et al. JOURNAL OF MOLECULAR BIOLOGY
- Circulating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes
- (2012) T. Gohda et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure
- (2012) Yifei Zhong et al. KIDNEY INTERNATIONAL
- Inflammation in Diabetic Nephropathy
- (2012) Andy K. H. Lim et al. MEDIATORS OF INFLAMMATION
- Tubular Atrophy and Interstitial Fibrosis After Renal Transplantation Is Dependent on Galectin-3
- (2012) Zexu Dang et al. TRANSPLANTATION
- Notice
- (2012) Kidney International Supplements
- Effect of CC Chemokine Receptor 2 CCR2 Blockade on Serum C-Reactive Protein in Individuals at Atherosclerotic Risk and With a Single Nucleotide Polymorphism of the Monocyte Chemoattractant Protein-1 Promoter Region
- (2011) Jim Gilbert et al. AMERICAN JOURNAL OF CARDIOLOGY
- Antiproteinuric Effect of Chemokine C-C Motif Ligand 2 Inhibition in Subjects with Acute Proliferative Lupus Nephritis
- (2011) Alessandro Ble et al. AMERICAN JOURNAL OF NEPHROLOGY
- The proximal tubule in the pathophysiology of the diabetic kidney
- (2011) Volker Vallon AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and MicroalbuminuriaAn Analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications CohortMicroalbuminuria Outcomes in Type 1 Diabetes
- (2011) Ian H. de Boer ARCHIVES OF INTERNAL MEDICINE
- The Inflammatory Cytokines TWEAK and TNF Reduce Renal Klotho Expression through NF B
- (2011) J. A. Moreno et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes
- (2011) Sufyan G. Sayyed et al. KIDNEY INTERNATIONAL
- HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II
- (2011) Maria D Sanchez-Niño et al. LABORATORY INVESTIGATION
- Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
- (2011) Helga Ellingsgaard et al. NATURE MEDICINE
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
- (2011) Juan F. Navarro-González et al. Nature Reviews Nephrology
- Tyrphostins as Potential Therapeutic Agents for Acute Kidney Injury
- (2010) S. Goncalves et al. CURRENT MEDICINAL CHEMISTRY
- Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation: A randomized, double-blind, placebo-controlled, crossover, 32-week study
- (2010) P. P. Sfikakis et al. DIABETES CARE
- BASP1 Promotes Apoptosis in Diabetic Nephropathy
- (2010) M. D. Sanchez-Nino et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- TGF- Mediates Genetic Susceptibility to Chronic Kidney Disease
- (2010) D. Laouari et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- NF- B in Renal Inflammation
- (2010) A. B. Sanz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Suppressors of Cytokine Signaling Abrogate Diabetic Nephropathy
- (2010) G. Ortiz-Munoz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The expanding spectrum of biological actions of vitamin D
- (2010) J. Rojas-Rivera et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
- (2009) C. M. Larsen et al. DIABETES CARE
- Modulation of CCR2 in rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled clinical trial
- (2008) Clarissa E. Vergunst et al. ARTHRITIS AND RHEUMATISM
- Enhanced Expression of Janus Kinase-Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
- (2008) C. C. Berthier et al. DIABETES
- Role of Remission Clinics in the Longitudinal Treatment of CKD
- (2008) P. Ruggenenti et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Association of Urinary Inflammatory Markers and Renal Decline in Microalbuminuric Type 1 Diabetics
- (2008) P. P. Wolkow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Death Ligand TRAIL in Diabetic Nephropathy
- (2008) C. Lorz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The MIF Receptor CD74 in Diabetic Podocyte Injury
- (2008) M. D. Sanchez-Nino et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Interleukin-6 regulates pancreatic -cell mass expansion
- (2008) H. Ellingsgaard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More